1. Takes RP, Baatenburg de Jong RJ, Schuuring E, Litvinov SV, Hermans J, Van Krieken JH. Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell. Anticancer Res 1998; 18(6B): 4793-4800.
2. Freier K, Joos S, Flechtenmacher C, Devens F, Benner A, Bosch FX, Lichter P, Hofele C.Tissue microarray reveals prevalence of oncogene amplification in head and neck squamous cell carcinoma (HNSCC). Correlation with localization, stage and clinical outcome. Cancer Res 2003; 63(6): 1179-1182.
3. Akervall JA, Michalides RJ, Mineta H, Balm A, Borg A, Dictor MR, Jin Y, Loftus B, Mertens F, Wennerberg JP. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 1997; 79(2): 380-389.
4. Gleich L, Salamore F. Molecular Genetics of Head and Neck Cancer. Cancer Control 2002; 9: 369-378.
5. Nadal A, Cardesa A. Molecular biology of laryngeal squamous cell carcinoma. Virchows Arch 2003; 442(1): 1-7.
6. Chana JS, Grover R, Wilson GD, Hudson DA, Forders M, Sanders R, Grobbelaar AO. The prognostic importance of c-myc oncogene expression in head and neck melanoma. Ann Plast Surg 2001; 47(2): 172-177.
7. Akervall J, Bockmuehl U. The gene ratios c-MYC: cyclin-dependent kinase (CDK)N2A and CCND1: CDKN2A correlate with poor prognosis in squamous cell carcinoma of head and neck cancer. Clin Cancer Res 2003; 9(5): 1750-1755.
8. de la Guardia C, Casiano CA, Trinidad-Pinedo J, Baez A. CENP-F gene amplification and overexpression in head and neck squamous cell carcinoma. Head Neck 2001; 23(2): 104-112.
9. Grandis J, Zeng Q, Drenning S. Epidermal growth factor receptor-mediated stat3 signaling blocks apoptosis in head and neck cancer. Laryngoscope 2000; 110 (5): 868-874.
10. www.discover.pitt.edu/media/pcc020423/UPCI headand neck.html
11. Schneider M. Head and neck cancer. Cancer Futures 2004; 3(1): 11-18.
12. Khan AJ, King BL, Smith BD, Smith GL, DiGoivanna MP, Carter D, Haffty BG. Characterization of HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma. Clin Cancer Res 2002; 8(2): 540-548.
13. Rodrigo JP, Ramos S, Lazo PS, Alvarez I, Suarez C. Amplification of ERBB oncogenes in squamous cell carcinoma of the head and neck. Eur J Cancer 1996; 32A(11): 2004-2010.
14. Resto VA, Caballero OL, Buta MR, Westra WH, Wu L, Westendorf JM, Jen J, Hieter P, Sindransky D. A putative oncogenic role for MPP11 in head and neck squamous cell carcinoma. Cancer Res 2000; 60(19): 5529-5535.
15. Redon R, Hussenet T, Bour G, Caulee K, Jost B, Muller D, Abecassis J, du Manoir S. Amplicon mapping and transcriptional analysis pinpoint cyclin L as a candidate oncogene in head and neck cancer. Cancer Res 2002; 62(21): 6211-6217.
16. Singh B, Stoffel A, Gogineni S, Poluri A, Pfister DG, Shaha AR, Pathak A, Bosl G, Cordon-Cardo C, Shah JP, Rao PH. Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinoma. Am J Pathol 2002; 161(2): 365-371.
17. www.infobiogen.fr/services/chromcancer/Tumors/ HeadNeckSquamID5090.html
18. Choi HR, Tucker SA, Huang Z, Gillenwater AM, Luna MA, Batsakis JG, El-Naggar AK. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis; Int J Oncol 2003; 22(2): 409-414.
19. Khademi B, Shirazi FM, Vasei M, Gandomi B, Modjtahedi H, Pezeshki AM, Ghageri A. The expression of p53, c-erbB-1 and c-erbB-2 molecules and their correlation with prognostic markers in patients with head and neck tumors. Cancer Lett 2002; 184(2): 223-230.
20. Lydiatt WM, Davidson BJ, Schantz SP, Caruana S, Chaganti RS. 9p21 Deletion correlates with recurrence in head and neck cancers. Head Neck 1998; 20(2): 113-118.
21. Forastiere A, Koch W, Trotti A, Sindranski D. Head and Neck cancer. N Engl J Med 2001; 345(26): 1890-1900.
22. Rodrigo JP, Gonzales MV, Lazo PS, Ramos S, Alvarez I, Garcia LA, Suarez C. Genetic alteration in squamous cell carcinoma of the hypopharynx with correlations to clinicopathological features. Oral Oncol 2002; 38(4): 357-363.
23. Gunduz M, Ouchida M, Fukushima K, Ito S, Jitsumori Y, Nakashima T, Nagai N, Nishzaki K, Shimizu K. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancer. Oncogene 2002; 21(28): 4462-4470.
24. Reis PP, Rogatto SR, Kowalski LP, Nishimoto IN, Montovani JC, Corpus G, Squire JA, Kamel-Reid S. Quantitative real-time PCR identifies a critical region of deletion on 22q13 related to prognosis in oral cancer. Oncogene 2002; 21(42): 6480-6487.
25. Poli-Frederico RC, Bergamo NA, Reis PP, Kowalski LP, Zielenska M, Squire JA, Rogatto SR. Chromosome 22q a frequent site of loss in human head and neck carcinoma. Head Neck 2000; 22(6): 585-590.
26. Jamieson T, Brizel D, Killian J, Oka Y, Jang H, Fu X, Clogh R, Vollmer R, Anscher M, Jirtle R. M6P/ IGF2R loss of heterozygosity in head and neck cancer associated with poor patients prognosis: BMC Cancer 2003; 3: 4.
27. Squire JA, Bayani J, Luk C, Unwin L, Tokunaga J, MacMillan C, Irish J, Brown D, Gullane P, Kamel-Reid S. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysis. Head Neck 2002; 24(9): 874-887.
28. Bockmuhl U, Petersen S, Schmidt S, Wolf G, Jahnke V, Dietel M, Petersen I. Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas. Cancer Res 1997; 57(23): 5213-5216.
29. Bockmuhl U, Schluns K, Kuchler I, Peterson S and Peterson I. Genetic imbalances with impact on survival in head and neck cancer patients. AM J Pathol 2000; 157(2): 369-375.
30. Bockmuhl U, Schluns K, Schmidt S, Matthias S, Petersen I. Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma. Genes Chrom Cancer 2002; 33(1): 29-35.
31. Gonzalez H, Gujrati M, Frederick M, Henderson Y, Arumugam J, Spring P, Mitsudo K, Kim H, Clayman G. Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2003; 129(7): 754-759.
32. Ginos M, Page G, Michalowicz B, Patel K, Volker S, Pambuccian S, Ondrey F, Adams G, Gaffney P. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 2004; 64(1): 55-63.
33. Sok J, Kuriakose M, Mahajan V, Pearlman A, DeLacure M, Chen F, MD. Tissue-specific gene expression of head and neck squamous cell carcinoma in vivo by complementary DNA microarray analysis. Arch Otolaryngol Head Neck Surg 2003; 129(7): 760-770.
34. Belbin T, Singh B, Barber I, Socci N, Wenig B, Smith R, Prystowsky M, Childs G. Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res 2003; 62(4): 1184-1190.
35. Quon H, Liu FF, Cummings BJ. Potential molecular prognostic markers in head and neck squamous cell carcinoma. Head Neck 2001; 23(2): 147-159.
